×
About 114,676 results

ALLMedicine™ Multiple Sclerosis Center

Research & Reviews  52,997 results

Diagnosis and Treatment of Multiple Sclerosis: A Review.
https://doi.org/10.1001/jama.2020.26858
JAMA McGinley MP, Goldschmidt CH et. al.

Feb 23rd, 2021 - Multiple sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system characterized by inflammatory demyelination with axonal transection. MS affects an estimated 900 000 people in the US. MS typically presents ...

Emerging Therapeutic Applications for Fumarates.
https://doi.org/10.1016/j.tips.2021.01.004
Trends in Pharmacological Sciences; Hoogendoorn A, Avery TD et. al.

Feb 23rd, 2021 - Fumarates are successfully used for the treatment of psoriasis and multiple sclerosis. Their antioxidative, immunomodulatory, and neuroprotective properties make fumarates attractive therapeutic candidates for other pathologies. The exact working ...

The Reporting of Race and Ethnicity in Medical and Science Journals: Comments Invited.
https://doi.org/10.1001/jamaneurol.2020.5520
JAMA Flanagin A, Frey T et. al.

Feb 22nd, 2021 - Pediatric-onset multiple sclerosis (PoMS) is associated with significant cognitive and physical disability. Whether this disability translates into differences in educational achievements and earnings is unknown. To evaluate the association betwee...

Feasibility and efficacy of a physical activity intervention for managing restless legs...
https://doi.org/10.1016/j.msard.2021.102836
Multiple Sclerosis and Related Disorders; Cederberg KLJ, Motl RW

Feb 22nd, 2021 - This pilot randomized controlled trial examined the feasibility and efficacy of a physical activity behavior change intervention for improving restless legs syndrome (RLS) severity and secondary sleep outcomes among a sample of adults with multipl...

see more →

Guidelines  107 results

Fall Prevention for People With Multiple Sclerosis Who Use Wheelchairs and Scooters.
https://doi.org/10.1016/j.apmr.2020.10.107
Archives of Physical Medicine and Rehabilitation; Rice LA, Yarnot R et. al.

Jan 19th, 2021 - Fall Prevention for People With Multiple Sclerosis Who Use Wheelchairs and Scooters.|2021|Rice LA,Yarnot R,Peterson EW,Backus D,Sosnoff J,|

Serum neurofilament light as a biomarker in progressive multiple sclerosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538221
Neurology Kapoor R, Smith KE et. al.

Jul 17th, 2020 - There is an unmet need in multiple sclerosis (MS) therapy for treatments to stop progressive disability. The development of treatments may be accelerated if novel biomarkers are developed to overcome the limitations of traditional imaging outcomes...

Practical Sleep Information for People With Multiple Sclerosis.
https://doi.org/10.1016/j.apmr.2020.03.009
Archives of Physical Medicine and Rehabilitation; Siengsukon C, Karahan AY et. al.

May 13th, 2020 - Practical Sleep Information for People With Multiple Sclerosis.|2020|Siengsukon C,Karahan AY,Strober L,|

Immediate and Sustained Effects of Interventions for Changing Physical Activity in People with Multiple Sclerosis: Meta-Analysis of Randomized Controlled Trials
https://www.archives-pmr.org/article/S0003-9993(20)30217-3/pdf
Archives of Physical Medicine & Rehibilitation; Kim Y

Apr 24th, 2020 - To examine the immediate and sustained effects of interventions for changing physical activity behavior in people with multiple sclerosis (MS), and explore factors that might moderate intervention effects on physical activity behavior (e.g., inter...

Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162735/
Neurol Sci.; Bonavita S

Apr 16th, 2020 - We propose a possible approach for the remote monitoring of infection risk in people with multiple sclerosis, especially those on immunosuppressant drugs, during COVID-19 pandemic. We developed a digital triage tool to be sent to patients to quick...

see more →

Drugs  371 results see all →

Clinicaltrials.gov  56,163 results

Diagnosis and Treatment of Multiple Sclerosis: A Review.
https://doi.org/10.1001/jama.2020.26858
JAMA McGinley MP, Goldschmidt CH et. al.

Feb 23rd, 2021 - Multiple sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system characterized by inflammatory demyelination with axonal transection. MS affects an estimated 900 000 people in the US. MS typically presents ...

Emerging Therapeutic Applications for Fumarates.
https://doi.org/10.1016/j.tips.2021.01.004
Trends in Pharmacological Sciences; Hoogendoorn A, Avery TD et. al.

Feb 23rd, 2021 - Fumarates are successfully used for the treatment of psoriasis and multiple sclerosis. Their antioxidative, immunomodulatory, and neuroprotective properties make fumarates attractive therapeutic candidates for other pathologies. The exact working ...

The Reporting of Race and Ethnicity in Medical and Science Journals: Comments Invited.
https://doi.org/10.1001/jamaneurol.2020.5520
JAMA Flanagin A, Frey T et. al.

Feb 22nd, 2021 - Pediatric-onset multiple sclerosis (PoMS) is associated with significant cognitive and physical disability. Whether this disability translates into differences in educational achievements and earnings is unknown. To evaluate the association betwee...

Feasibility and efficacy of a physical activity intervention for managing restless legs...
https://doi.org/10.1016/j.msard.2021.102836
Multiple Sclerosis and Related Disorders; Cederberg KLJ, Motl RW

Feb 22nd, 2021 - This pilot randomized controlled trial examined the feasibility and efficacy of a physical activity behavior change intervention for improving restless legs syndrome (RLS) severity and secondary sleep outcomes among a sample of adults with multipl...

see more →

News  4,915 results

Fast Five Quiz: Secondary Progressive Multiple Sclerosis
https://reference.medscape.com/viewarticle/917635

Feb 15th, 2021 - Multiple sclerosis (MS) is a chronic, immune-mediated inflammatory disease that attacks the myelin of the central nervous system. The most common type is relapsing-remitting multiple sclerosis (RRMS), which accounts for approximately 85% of MS cas...

Accident Gives MS Doctor Insight Into Patients' Lives
https://www.medscape.com/viewarticle/945895

Feb 15th, 2021 - Editor's note: The original text has been revised and updated. As Gavin Giovannoni, MBBCh, PhD, an esteemed British multiple sclerosis (MS) expert, set out for his Saturday morning run on Nov. 7, 2020, the world's weighty problems swirled through ...

MS Bears No Effect on Certain Pregnancy Complications, Stillbirth, or Congenital Deformation
https://www.medscape.com/viewarticle/945463

Feb 7th, 2021 - Multiple sclerosis (MS) may not pose a higher risk for complications in pregnant women, according to a new study published online Feb. 3 in Neurology Clinical Practice. While pregnancy and childbirth are not regarded as conditions that engender hi...

FDA Okays IM Administration for Peginterferon Beta-1a in MS
https://www.medscape.com/viewarticle/945023

Jan 31st, 2021 - The US Food and Drug Administration (FDA) has approved intramuscular (IM) administration of peginterferon β-1a (Plegridy, Biogen) for patients with relapsing forms of multiple sclerosis (MS). "The new IM administration offers people living with re...

Is the EDSS an Adequate Measure in Secondary Progressive MS?
https://www.medscape.com/viewarticle/944938

Jan 28th, 2021 - Clinical trials enrolling patients with progressive multiple sclerosis (MS) commonly use the Expanded Disability Status Scale (EDSS), an instrument that looks at impairment across several different functional domains, as a primary outcome measure....

see more →

Patient Education  123 results see all →